Trade AbbVie ^ABBV

Miller Howard Investments Inc. NY Sells 3,294 Shares of AbbVie Inc. $ABBV

OP Asset Management Ltd Purchases Shares of 310,902 AbbVie Inc. $ABBV

AbbVie Stock Leads 3 Cash Flow Picks Trading Below Estimated Value

3 Psychedelic Stocks In The Space AbbVie Bet A Billion Dollars On

AbbVie Stock And 2 Cash Flow Picks Worth A Closer Look

Canaccord Says AbbVie's (ABBV) Apogee Deal Strengthens Long-Term Growth Outlook

Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial

AbbVie (NYSE:ABBV) Trading 6.3% Higher - Still a Buy? - Zolmax

Why I Can't Stop Buying This Unstoppable Dividend Juggernaut

AbbVie's $11 Billion Immunology Bet

FDA Complete Response Letter (CRL) Explained: What It Means For Biotech Stocks

64 Years Old With $1.1 Million in a Traditional IRA. Here's Where I'm Allocating Capital

BOTOX® Cosmetic (onabotulinumtoxinA) Introduces The Confidence Collective's Entrepreneur Class of 2026 | Morningstar

After Apogee, 3 More Biotech Buyout Targets Wall Street Can't Stop Watching - 24/7 Wall St.

AbbVie Inc. $ABBV Shares Acquired by Signal Advisors Wealth LLC

SVB Wealth LLC Sells 10,374 Shares of AbbVie Inc. $ABBV

Great Place To Work Reveals Southeast Asia's Best Workplaces™ in Healthcare & Biopharma

SVB Wealth LLC Reduces Position in AbbVie Inc. $ABBV - Daily Political

Long-term follow-up of the transplant-eligible cohort of the EMN12/HOVON-129 study for primary plasma cell leukemia patients

Apogee Therapeutics downgraded to Hold from Buy at TD Cowen

AbbVie Just Sparked a 46% Rally in Apogee. Here's Why This $10.9 Billion Deal Could Be a Win for AbbVie Investors.

Therapeutics Stocks Q1 Recap: Benchmarking Biogen (NASDAQ:BIIB)

AbbVie (NYSE:ABBV) Receives "Overweight" Rating from Piper Sandler - Markets Daily

AbbVie (NYSE:ABBV) Receives "Overweight" Rating from Piper Sandler - Zolmax

AbbVie (ABBV) Is Buying Apogee Therapeutics For $10.9 Billion To Rebuild Its Pipeline

AbbVie (ABBV) Gains EU Approval for Expanded Use of Hepatitis C Treatment Maviret

3 Biotech Takeover Targets Wall Street Is Watching After the Apogee Deal

AbbVie (ABBV) Secures EU Approval for Skyrizi in Pediatric Psoriasis Treatment

Apogee Therapeutics (NASDAQ:APGE) Stock Rating Lowered by Citigroup - Zolmax

Apogee Therapeutics (NASDAQ:APGE) Stock Rating Lowered by Citigroup - Markets Daily

Apogee Therapeutics (NASDAQ:APGE) Downgraded to Hold Rating by Citigroup - Stock Observer

AbbVie Announces European Commission Approval of SKYRIZI® for the Treatment of Pediatric Patients with Moderate to Severe Plaque Psoriasis | INN

Wells Fargo Maintains Overweight on AbbVie (ABBV), Sees Value in Apogee Acquisition

Why AbbVie Stock Jumped Today

Generate Investment Management Ltd Sells 5,261 Shares of AbbVie Inc. $ABBV - Daily Political

Apogee Therapeutics (APGE) Hits Fresh High on AbbVie $10.9B Merger

AbbVie: Apogee Acquisition Brings Significant Weight to Immunology Pipeline | Morningstar

AbbVie's Immunology Dominance Contributes to Its Wide Economic Moat | Morningstar

2026's Biggest Biotech Myth: $10.9B Sale of a Phase II Drug from a 261 - Employee Company

ABBV's Acquisition Impacts Evommune's Outlook

Healthcare Stocks Gain in Mixed U.S. Session - Healthcare Roundup | Morningstar

Abbvie Inc to Acquire Apogee Therapeutics Call Transcript

The $11 Billion Reason Abbvie Stock Is Up Today

AbbVie is buying a biotech company working on an experimental eczema drug for $10.9 billion | Morningstar

Stock market today: S&P 500, Nasdaq slide as Big Tech, SpaceX hammered

Abbvie acquiring Apogee for $10.9B, Coca-Cola vs. IRS in appeals court

AbbVie (ABBV) Acquires Apogee Therapeutics for $10.9 Billion

AbbVie (NYSE:ABBV) Stock Price Up 6.3% - Should You Buy? - Stock Observer

AbbVie Up Nearly 7%, on Pace for Largest Percent Increase Since November 2020 - Data Talk | Morningstar

Stock market today: Dow rises, S&P 500 and Nasdaq fall as SpaceX stock declines and US-Iran peace talks remain in focus

Dow Jones Top Company Headlines at 11 AM ET: Chevron Strikes Power Deal With Microsoft for West Texas AI Data Center | AbbVie ... | Morningstar

Apogee Therapeutics Stock Soars 47% After AbbVie Acquisition

Why AbbVie Is Spending $11 Billion to Buy Apogee Therapeutics

AbbVie on Pace for Largest Percent Increase Since October 2025 - Data Talk | Morningstar

AbbVie to acquire Apogee Therapeutics in $10.9B deal

AbbVie (ABBV) Acquires Apogee Therapeutics, Impact on Regeneron Analyzed

AbbVie To Acquire Immunology Drug Maker Apogee For $10.9 Bln Cash; Shares Climb

AbbVie to Acquire Apogee Therapeutics in $10.9 Billion Deal

AbbVie to buy immunology drugmaker Apogee for close to $11B

Market Highlights: Getty Images Soars 179% on OpenAI Partnership, AbbVie Plans $11B Acquisition

AbbVie (ABBV) to Acquire Apogee Therapeutics for $10.9 Billion

AbbVie (ABBV) Set to Acquire Apogee Therapeutics for $10.9 Billion

AbbVie to Buy Apogee Therapeutics for $10.9 Billion in Cash - Update | Morningstar

AbbVie (ABBV) Pursues Apogee Therapeutics for Strategic Acquisition

Stocks making the biggest moves premarket: APGE, SPCX, ACA

AbbVie To Buy Apogee Therapeutics For $135.11/Share In Cash

AbbVie strikes $10.9 billion deal for Apogee Therapeutics

AbbVie Inc. $ABBV Shares Purchased by Westmount Partners LLC - Zolmax

AbbVie Inc. $ABBV Shares Purchased by Westmount Partners LLC

Uhlmann Price Securities LLC Buys 7,523 Shares of AbbVie Inc. $ABBV - Markets Daily

AbbVie (ABBV) Stock Dips as $10.9B Apogee Therapeutics Acquisition Nears Completion

AbbVie's (ABBV) Allergan Aesthetics Wins FDA Approval for Skinvive by Juvederm

Park National Corp OH Acquires 5,910 Shares of AbbVie Inc. $ABBV

Diversified Trust Co Buys 8,430 Shares of AbbVie Inc. $ABBV

3 Excellent Dividend Stocks to Buy on the Dip

Autologous stem cell transplantation for AL amyloidosis: a multicenter summary of outcomes 2010-2020

The 2 Factors That Will Decide Whether XLV Finally Catches the S&P 500 in 2026 - 24/7 Wall St.

The 2 Factors That Will Decide Whether XLV Finally Catches the S&P 500 in 2026 - AOL

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Moderna (MRNA)

Analysts Conflicted on These Healthcare Names: AbbVie (ABBV) and Moderna (MRNA)

AbbVie's biggest deal since 2019 could land soon

Union Savings Bank Makes New Investment in AbbVie Inc. $ABBV - Markets Daily

Hsbc Holdings PLC Increases Stock Holdings in AbbVie Inc. $ABBV

Winthrop Partners WNY LLC Makes New $1.32 Million Investment in AbbVie Inc. $ABBV - Zolmax

Fund Advisors of America Inc FL Invests $897,000 in AbbVie Inc. $ABBV - Markets Daily

Meadowbrook Advisors Group LLC Takes Position in AbbVie Inc. $ABBV

4,724 Shares in AbbVie Inc. $ABBV Acquired by Union Savings Bank

AbbVie Inc. $ABBV Shares Purchased by Hsbc Holdings PLC

9,655 Shares in AbbVie Inc. $ABBV Purchased by SHP Wealth Management

AbbVie Inc. $ABBV Shares Acquired by Corient Private Wealth LLC

AbbVie Inc. (NYSE:ABBV) Receives Average Recommendation of "Moderate Buy" from Analysts

SHP Wealth Management Invests $2.21 Million in AbbVie Inc. $ABBV - Stock Observer

LME to Permanently Restrict Large Positions Amidst Low Inventory

The Future of Payments: Fragmentation, Digital Assets, and AI

Daily Market Review and Trend Analysis: October 22

Crypto Cities: Challenges and Opportunities for a Decentralized Future

OpenAI's Atlas Browser: A Glimpse into the Future of AI Agents on the Web

Precious Metals Retreat Amid Easing Trade Tensions and Rate Cut Expectations

Australian Gold Rush: Record Prices Spark Queues and Investment Debate

Join markets.com and Bryan Habana at Finance Magnates Africa Summit 2023!